TRVI: Haduvio’s $15B Market Potential and TSMC’s Nalbuphine Supply Risks
724FinanceKaptan Rıza Deniz
Key Highlights
Trevi Therapeutics (TRVI) hissedarı, Haduvio’nun kronik öksürük tedavisi için başarılı klinik verilerinden sonra %9.85 artış gösterdi. Şirket, Haduvio
Trevi Therapeutics (TRVI) shares surged 9.85% after reporting strong clinical trial results for Haduvio, its chronic cough treatment candidate. The company is targeting a $14-15 billion addressable market for chronic cough, which is expected to grow at a 6% CAGR from $9 billion in 2024. TRVI plans to launch a Phase 2b trial for non-IPF ILD-related chronic cough in the second half of 2026. Hedge funds are increasing exposure ahead of potential approval.
TSMC’s supply chain risks in nalbuphine production, coupled with China-US semiconductor tensions, could disrupt TRVI’s timeline. The reliance on rare earth elements from the US threatens production continuity.
Related News & Analysis
View All →
Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout
Singh Joins Mayfield: A New Era for Chip Investments
Ramp Unveils Model Router, Steering the AI Landscape into a New Era
WNBA’s Landmark Pay Raise: 364% Surge in Player Wages Sparks Labor Milestone
Gen Z Rewrites the American Dream in the Great Postponement
Inertia Enterprises Cuts Fusion Fuel Loading to Hours, Shaking the Energy Market
Latest Market News
All News →![[YYAPI] YEŞİL YAPI ENDÜSTRİSİ A.Ş.
Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[YYAPI] YEŞİL YAPI ENDÜSTRİSİ A.Ş. Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu
Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout
Moderna’s Personalized mRNA Gamble: Oncology Revolution or Market Bubble?
[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş. Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında
Norway’s July Oil Production Slump Sends Shockwaves Through European Energy Markets
